Investor Presentaiton slide image

Investor Presentaiton

Journey to 11x Growth in India Exploration Phase: 2000-2010 2000 Manufacturing JV with New Chemi 2002 Started EHD (Public Health) business 2005 SCIL incorporated in India as EHD (HHI) distribution company 2001 Started ASD business 2003 Robust growth driven by Organic & In-organic expansion Acquisition of New Chemi and integration with SCIL Expanded the business to include animal nutrition chemicals Acquired product - 'Sulfosulfuron' Leader rights from Monsanto Acquired EHD (HHI) unit from Bayer Vapi 2006 Aggressive Growth Phase: 2011 – 2021 Setting-up new organization, control system, PCO function and innovative sales team Acquisition of Excel Crop Care Merger completion 2010 Started Animal Nutrition 2 Sales INR 2 Bn SCIL 2.0 1st full year of operations 26.4 24.2 11% 22.2# 19.4# 17.4 18.2 16.3 16.9 13.2 12.7 11.9 Rs. Bn 11.4 9.7 10.3 9.0 9.5 9.8 7.8 6.9 ECC 7.2 6.5 7.1 7.9 8.5 9.0 10.0 SCIL 4.5 4.9 2.3 FY10-11 FY11-12 FY12-13 FY13-14 FY14-15 FY15-16 FY16-17 FY17-18 FY18-19 FY19-20 FY20-21 #Inter-company transactions are eliminated. Other operating income is included HHI Household Insecticides 14
View entire presentation